Fig. 3
From: Use of non-small cell lung cancer multicellular tumor spheroids to study the impact of chemotherapy
Pathway analysis on the effect of carboplatin-paclitaxel or carboplatin-gemcitabine combinations exposure in ADCA117 MCTS. ADCA117 MCTS were treated with a combination of carboplatin (50µM)-paclitaxel (150nM) (CaPa) or gemcitabine (100 nM) (CaGe) repeated 3 times. mRNA were extracted and analyzed using 3’RNA sequencing. (A, B) KEGG pathways enrichment of CaPa (A) or CaGe (B)-dysregulated mRNAs